Healthcare Realty COO sells 21K shares at $19.11

Healthcare Realty Trust’s EVP and COO reported an open‑market sale of 21,000 shares, leaving him with 276,338 shares directly held.

Rhea-AI Filing Summary

Healthcare Realty Trust Inc (HR) executive vice president and chief operating officer Robert E. Hull reported selling 21,000 shares of common stock on September 8, 2026 in an open-market transaction at a weighted-average price of about $19.11 per share. After this sale, he directly holds 276,338 shares of Healthcare Realty Trust Inc common stock.

The sale was executed in multiple trades within a narrow price range of $19.11 to $19.12 per share, with the reported price representing the weighted-average sales price. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Net Seller: 21,000 shares

Net Sell 1 txn

Insider Hull Robert E

Role EVP and COO

Sold 21,000 shs ($401K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	21,000	$19.11	$401K

Holdings After Transaction: Common Stock — 276,338 shares (Direct)

Footnotes (1)

1. F1. This transaction was executed in multiple trades at prices ranging from $19.11 to $19.12. The price reported above reflects the weighted-average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request by the SEC staff, the issuer or a security holder of the issuer.

Key Figures

Shares sold: 21,000 shares Weighted-average sale price: $19.11 per share Post-transaction holdings: 276,338 shares +2 more

5 metrics

Shares sold 21,000 shares Common stock sale reported for September 8, 2026

Weighted-average sale price $19.11 per share Open-market sale of HR common stock on September 8, 2026

Post-transaction holdings 276,338 shares Direct holdings after the reported sale by the EVP and COO

Price range of executed trades $19.11–$19.12 per share Range of prices for multiple trades comprising the reported sale

Net shares sold in filing 21,000 shares Net sell direction across all transactions in this Form 4

Key Terms

weighted-average sales price, open market, Rule 10b5-1

3 terms

weighted-average sales price financial

"The price reported above reflects the weighted-average sales price."

open market financial

"Sale in open market or private transaction"

An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.

Rule 10b5-1 regulatory

"No Rule 10b5-1 trading plan is reported for this transaction"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HR’s EVP and COO report in this Form 4?

Robert E. Hull, EVP and COO of Healthcare Realty Trust Inc (HR), reported an open‑market sale of 21,000 shares of common stock on September 8, 2026 at a weighted‑average price of about $19.11 per share.

How many HR shares does the reporting officer hold after this transaction?

After the September 8, 2026 sale, Robert E. Hull directly holds 276,338 shares of Healthcare Realty Trust Inc common stock, according to the Form 4 filing.

At what prices were the HR shares sold in this Form 4 transaction?

The 21,000 Healthcare Realty Trust Inc shares were sold in multiple trades at prices ranging from $19.11 to $19.12 per share, with the Form 4 reporting a weighted‑average sales price of about $19.11 per share.

Was the HR insider’s share sale made under a Rule 10b5-1 trading plan?

The Form 4 indicates that the document‑level Rule 10b5‑1 checkbox is not checked, and the footnotes do not describe any plan, so no Rule 10b5‑1 trading plan is reported for this sale.

Is the HR insider’s sale characterized as direct or indirect ownership in the Form 4?

The Form 4 reports the 21,000‑share sale and the remaining 276,338 shares as held under direct ownership by Robert E. Hull, with no intermediary entity described in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/09/2026 - 10:58 AM Accepted by SEC EDGAR 09/09/2026 - 10:58 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hull Robert E

(Last) (First) (Middle)

3310 WEST END AVENUE

SUITE 700, ATTENTION: ANDREW LOOPE

(Street)

NASHVILLE TENNESSEE 37203

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Healthcare Realty Trust Inc [ HR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/08/2026		S		21,000	D	$19.11(1)	276,338	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $19.11 to $19.12. The price reported above reflects the weighted-average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request by the SEC staff, the issuer or a security holder of the issuer.

Remarks:

	/s/ Andrew E. Loope as power of attorney	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)